Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon cancer have ...

It's stage III and contained.

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

Neoadjuvant chemotherapy (NAC) in colorectal cancer aims to downstage locally advanced tumours, increase rates of complete resection and address micrometastatic disease before surgery. Radiological ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. While eight months pregnant, Lori Charney developed ...

Recurrence risk for stage II to III colon cancer falls below 0.5% 6 years posttreatment, suggesting a potential cure definition. The study analyzed data from 15 phase 3 trials, involving 35,213 ...